Skip to content

Transverse vs. Longitudinal Serratus Anterior Plane Block in Breast Surgery

Efficacy of Transverse Versus Longitudinal Ultrasound Probe Orientation for Serratus Anterior Plane Block on Postoperative Pain in Breast Surgery: A Prospective Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07739277
Enrollment
70
Registered
2026-07-31
Start date
2026-08-06
Completion date
2027-02-19
Last updated
2026-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pain, Breast Surgery, Fascial Plane Block, Mastectomy, Pain, Postoperative

Keywords

Serratus Anterior Plane Block, Regional Anesthesia, Postoperative Analgesia, Breast Surgery

Brief summary

The aim of this prospective, randomized controlled trial is to compare the analgesic efficacy of transverse versus longitudinal ultrasound probe orientations during Serratus Anterior Plane (SAP) block in patients undergoing breast surgery. The study hypothesizes that the longitudinal approach (probe parallel to the ribs) may provide better craniocaudal spread of the local anesthetic, thereby resulting in lower postoperative Visual Analog Scale (VAS) scores and reduced opioid consumption compared to the standard transverse approach.

Interventions

PROCEDURETransverse SAP Block

Transverse serratus anterior plane block will be performed on the patients using 20 mL of 0.375% bupivacaine under ultrasound guidance.

PROCEDURELongitudinal SAP Block

Longitudinal serratus anterior plane block will be performed on the patients using 20 mL of 0.375% bupivacaine under ultrasound guidance.

Sponsors

Ankara Etlik City Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged between 18 and 65 years * American Society of Anesthesiologists (ASA) physical status I, II, or III * BMI between 18 - 30 kg/m2 * Patients scheduled for elective breast surgery * Ability to provide written informed consent

Exclusion criteria

* Known allergy to local anesthetics * Infection at the injection site * Severe coagulopathy or use of anticoagulants * Chronic opioid use or history of neuropathic pain

Design outcomes

Primary

MeasureTime frameDescription
Postoperative Pain Intensity4 hour after surgeryPain will be assessed using a visual analog scale from 0 mm (no pain) to 100 mm (worst pain) at rest. Pain assessment will be made at 4 hour after surgery.

Secondary

MeasureTime frameDescription
Postoperative Pain IntensityUp to 24 hoursPain will be assessed using a visual analog scale from 0 mm (no pain) to 100 mm (worst pain) at rest and when coughing. Pain assessment will be made at 1, 8, 12, and 24 hours after surgery.
Total Postoperative Opioid ConsumptionUp to 24 hoursThe total amount of opioid consumed by the patient will be recorded.
Area Under Curve for PainUp to 24 hoursCumulative 24-hour pain burden calculated by the trapezoidal rule
Assessment of Sensory Blockade ExtentEvaluated at 20 minutes following block administration.Sensory extent will be assessed using pinprick testing with a 20-gauge hypodermic needle.

Countries

Turkey (Türkiye)

Contacts

CONTACTİbrahim MD Topcu
ibrahimtpc78@gmail.com05437860316
CONTACTMusa Ass. Prof Zengin
musazengin@gmail.com05071302750

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 8, 2026